|​Eli Lilly and Company (LLY): Among the Best Stocks to Buy While the Market Is Down

Eli Lilly and Company is considered a top stock to buy despite market downturns, largely due to its strategic acquisition of Kelonia Therapeutics for up to $7 billion. This deal is set to expand Eli Lilly’s oncology portfolio and diversify its business beyond increasingly competitive weight-loss drugs. Analysts are bullish on LLY, with a significant majority recommending a “Buy” rating and projecting over 38% upside.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments